首页> 外文期刊>Allergy, Asthma & Immunology Research >Management Practice of Allergic Rhinitis in China During the COVID-19 Pandemic
【24h】

Management Practice of Allergic Rhinitis in China During the COVID-19 Pandemic

机译:Covid-19大流行期间中国过敏性鼻炎的管理实践

获取原文
获取外文期刊封面目录资料

摘要

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which was provisionally named as “coronavirus disease 2019” (COVID-19) by the International Committee on Taxonomy of Viruses,1 is a newly identified member of human coronavirus species that has emerged recently and caused a highly infectious disease. COVID-19 has spread aggressively across the globe since it was first reported in December 2019,2 and declared as a pandemic by the World Health Organization on March 11. Up to April 7, 2020, 1.33 million and 83,071 cases of COVID-19 have been confirmed worldwide and in China, respectively.
机译:严重的急性呼吸综合征冠状病毒2(SARS-COV-2)被国际病毒分类委员会临时被命名为“2019年冠状病毒疾病2019”(Covid-19),是一个新发现的人冠状病毒物种成员最近出现并引起了一种高度传染病。 Covid-19自2019年12月首次报告的全球范围内积极蔓延,并于3月11日宣布为世界卫生组织宣布为大流行.2010年4月7日,133万和83,071例Covid-19案件在全球和中国确认。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号